• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail

Miacalcin (calcitonin-salmon) nasal spray

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) -- October 2009

 

Summary View

 

PRECAUTIONS

Drug Interactions
  • Concomitant use of calcitonin and lithium may lead to a reduction in plasma lithium concentrations due to increased urinary clearance of lithium. The dose of lithium may need to be adjusted.

ADVERSE REACTIONS

Immune system disorders
  • Hypersensitivity, anaphylaxis and anaphylactic shock